Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations

Abstract

Proinflammatory cytokines are potent mediators of numerous biological processes and are tightly regulated in the body. Chronic uncontrolled levels of such cytokines can initiate and derive many pathologies, including incidences of autoimmunity and cancer. Therefore, therapies that regulate the activity of inflammatory cytokines, either by supplementation of anti-inflammatory recombinant cytokines or by neutralizing them by using blocking antibodies, have been extensively used over the past decades. Over the past few years, new innovative biological agents for blocking and regulating cytokine activities have emerged. Here, we review some of the most recent approaches of cytokine targeting, focusing on anti-TNF antibodies or recombinant TNF decoy receptor, recombinant IL-1 receptor antagonist (IL-1Ra) and anti-IL-1 antibodies, anti-IL-6 receptor antibodies, and TH17 targeting antibodies. We discuss their effects as biologic drugs, as evaluated in numerous clinical trials, and highlight their therapeutic potential as well as emphasize their inherent limitations and clinical risks. We suggest that while systemic blocking of proinflammatory cytokines using biological agents can ameliorate disease pathogenesis and progression, it may also abrogate the hosts defense against infections. Moreover, we outline the rational need to develop new therapies, which block inflammatory cytokines only at sites of inflammation, while enabling their function systemically.

Bronchoalveolar Lavage Microvesicles Protect Burn-Injured Mice from Pulmonary Infection

“…IL-6 is a known inflammatory cytokine that has an effect on a variety of cells in the immune system, including macrophages 25 . A previous study has shown that along with other inflammatory markers, IL-6 is elevated in patients with bacterial pneumonia 26 .…”

Inhibition of TNF-α and IL-1 by compounds from selected plants for rheumatoid arthritis therapy: <i>In vivo</i> and <i>in silico</i> studies

“…There are several reports on the targeting of these enzymes for potential therapeutic applications [21]. In this study, drug targets for these proteins were identified and virtual screening was carried out.…”

Effects of phyto‐oestrogen quercetin on productive performance, hormones, reproductive organs and apoptotic genes in laying hens

“…High Bcl‐2 expression is closely related to oestrogen production and estrogen receptor expression (Andrew et al., ). However, Bcl‐2 expression may be influenced by other factors, such as local or systemic cytokines (Rider, Carmi, & Cohen, ). In present study, quercetin significantly down‐regulated the expression of Bax mRNA and up‐regulated the expression of Bcl‐2 mRNA.…”